More great news for DNA holders today with industry wide exposure for the Encrypgen platform with a feature article on blockchain genomics solutions on the top rated science journal New Scientist calling the start-up
" the vanguard of this movement ."
https://www.newscientist.com/article/2161707-why-big-pharma-might-pay-cryptocurrency-for-your-dna/
New Scientist is easily one of the most far reaching science journal with a readership of millions of science professionals around the world across all disciplines. The network effect may very well start here.
